Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute, 11957-11958 [2023-03826]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 37 / Friday, February 24, 2023 / Notices
Sterling Wisconsin LLC., W130N10497
Washington Drive, Germantown,
Wisconsin 53022–4448, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Lysergic Acid
Diethylamide.
Marihuana Extract ........
Marihuana .....................
Tetrahydrocannabinols
Mescaline .....................
5-Methoxy-N-NDimethyltryptamine.
Psilocybin .....................
Oliceridine .....................
Thebaine .......................
Alfentanil .......................
Drug
code
Schedule
7315
I
7350
7360
7370
7381
7431
I
I
I
I
I
7437
9245
9333
9737
I
II
II
II
The company plans to bulk
manufacture the listed controlled
substances to be commercially sold to
registered manufacturers/suppliers. In
reference to drug codes 7350
(Marihuana Extract), 7360 (Marihuana),
and 7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture
these drugs as synthetic. No other
activities for these drug codes are
authorized for this registration.
In
accordance with 21 CFR 1301.34(a), this
is notice that on January 10, 2023, S&B
Pharma LLC, 405 South Motor Avenue,
Azusa, California 91702, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–03839 Filed 2–23–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1153]
Controlled substance
Importer of Controlled Substances
Application: S&B Pharma LLC
4-Anilino-N-phenethyl-4piperidine (ANPP).
Tapentadol ....................
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
S&B Pharma LLC has applied
to be registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before March 27, 2023. Such
persons may also file a written request
for a hearing on the application on or
before March 27, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
ddrumheller on DSK120RN23PROD with NOTICES
DATES:
VerDate Sep<11>2014
18:15 Feb 23, 2023
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
Jkt 259001
Drug
code
Schedule
8333
II
9780
II
The company plans to import
intermediate forms of Tapentadol (9780)
for further manufacturing prior to
distribution to its customers. The
company plans to import ANPP (8333)
to bulk manufacture other controlled
substances for distribution to its
customers. No other activities for these
drug codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
11957
approved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–03829 Filed 2–23–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1150]
Bulk Manufacturer of Controlled
Substances Application: Scottsdale
Research Institute
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Scottsdale Research Institute,
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 25, 2023. Such
persons may also file a written request
for a hearing on the application on or
before April 25, 2023.
DATES:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on January 10, 2023,
Scottsdale Research Institute, 12815
North Cave Creek Road, Phoenix,
Arizona 85022, applied to be registered
as a bulk manufacturer of the following
basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
E:\FR\FM\24FEN1.SGM
24FEN1
11958
Federal Register / Vol. 88, No. 37 / Friday, February 24, 2023 / Notices
Controlled substance
Drug
code
Schedule
POSTAL REGULATORY COMMISSION
[Docket Nos. MC2023–112 and CP2023–115]
Marihuana Extract ........
Marihuana .....................
Tetrahydrocannabinols
7350
7360
7370
I
I
I
New Postal Products
Postal Regulatory Commission.
Notice.
AGENCY:
The company plans to bulk
manufacture the listed controlled
substances to support clinical trials and
distribution to their customers for
research purposes. No other activities
for these drug codes are authorized for
this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–03826 Filed 2–23–23; 8:45 am]
BILLING CODE P
LEGAL SERVICES CORPORATION
Sunshine Act Meetings
The Search Committee
for LSC Inspector General (Search
Committee) of the Legal Services
Corporation Board of Directors will
meet virtually on Tuesday, February 28,
2023. The meeting will commence at
11:00 a.m. EST and will continue until
the conclusion of the Committee’s
agenda.
PLACE: Public notice of virtual meetings.
LSC will conduct the February 28,
2023 meeting via Zoom.
STATUS: Closed.
MATTERS TO BE CONSIDERED:
TIME AND DATE:
ddrumheller on DSK120RN23PROD with NOTICES
Closed Session
1. Approval of Agenda.
2. Discuss the interviews of
candidates for the position of Legal
Services Corporation Inspector General.
3. Decide which candidates, if any, to
consider further.
4. Determine whether to conduct
further interviews of selected
candidates, discuss the questions the
Search Committee would like to ask,
and determine the dates of such further
interviews.
5. Adjourn.
CONTACT PERSON FOR MORE INFORMATION:
Cheryl DuHart, Administrative
Coordinator, Office of Legal Affairs, at
(202) 295–1621. Questions may also be
sent by electronic mail to duhartc@
lsc.gov.
Dated: February 21, 2023.
Stefanie Davis,
Senior Associate General Counsel for
Regulations.
[FR Doc. 2023–03923 Filed 2–22–23; 8:45 am]
BILLING CODE 7050–01–P
VerDate Sep<11>2014
18:15 Feb 23, 2023
Jkt 259001
ACTION:
The Commission is noticing a
recent Postal Service filing for the
Commission’s consideration concerning
a negotiated service agreement. This
notice informs the public of the filing,
invites public comment, and takes other
administrative steps.
DATES: Comments are due: February 28,
2023.
ADDRESSES: Submit comments
electronically via the Commission’s
Filing Online system at https://
www.prc.gov. Those who cannot submit
comments electronically should contact
the person identified in the FOR FURTHER
INFORMATION CONTACT section by
telephone for advice on filing
alternatives.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
David A. Trissell, General Counsel, at
202–789–6820.
SUPPLEMENTARY INFORMATION:
Table of Contents
I. Introduction
II. Docketed Proceeding(s)
I. Introduction
The Commission gives notice that the
Postal Service filed request(s) for the
Commission to consider matters related
to negotiated service agreement(s). The
request(s) may propose the addition or
removal of a negotiated service
agreement from the Market Dominant or
the Competitive product list, or the
modification of an existing product
currently appearing on the Market
Dominant or the Competitive product
list.
Section II identifies the docket
number(s) associated with each Postal
Service request, the title of each Postal
Service request, the request’s acceptance
date, and the authority cited by the
Postal Service for each request. For each
request, the Commission appoints an
officer of the Commission to represent
the interests of the general public in the
proceeding, pursuant to 39 U.S.C. 505
(Public Representative). Section II also
establishes comment deadline(s)
pertaining to each request.
The public portions of the Postal
Service’s request(s) can be accessed via
the Commission’s website (https://
www.prc.gov). Non-public portions of
the Postal Service’s request(s), if any,
can be accessed through compliance
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
with the requirements of 39 CFR
3011.301.1
The Commission invites comments on
whether the Postal Service’s request(s)
in the captioned docket(s) are consistent
with the policies of title 39. For
request(s) that the Postal Service states
concern Market Dominant product(s),
applicable statutory and regulatory
requirements include 39 U.S.C. 3622, 39
U.S.C. 3642, 39 CFR part 3030, and 39
CFR part 3040, subpart B. For request(s)
that the Postal Service states concern
Competitive product(s), applicable
statutory and regulatory requirements
include 39 U.S.C. 3632, 39 U.S.C. 3633,
39 U.S.C. 3642, 39 CFR part 3035, and
39 CFR part 3040, subpart B. Comment
deadline(s) for each request appear in
section II.
II. Docketed Proceeding(s)
1. Docket No(s).: MC2023–112 and
CP2023–115; Filing Title: USPS Request
to Add Priority Mail Express
International, Priority Mail
International, First-Class Package
International Service & Commercial
ePacket Contract 13 to Competitive
Product List and Notice of Filing
Materials Under Seal; Filing Acceptance
Date: February 17, 2023; Filing
Authority: 39 U.S.C. 3642, 39 CFR
3040.130 through 3040.135, and 39 CFR
3035.105; Public Representative:
Jennaca D. Upperman; Comments Due:
February 28, 2023.
This Notice will be published in the
Federal Register.
Erica A. Barker,
Secretary.
[FR Doc. 2023–03835 Filed 2–23–23; 8:45 am]
BILLING CODE 7710–FW–P
SMALL BUSINESS ADMINISTRATION
[Disaster Declaration #17767 and #17768;
California Disaster Number CA–00368]
Presidential Declaration Amendment of
a Major Disaster for Public Assistance
Only for the State of California
U.S. Small Business
Administration.
ACTION: Amendment 3.
AGENCY:
This is an amendment of the
Presidential declaration of a major
disaster for Public Assistance Only for
the State of California (FEMA–4683–
DR), dated 01/26/2023.
Incident: Severe Winter Storms,
Flooding, Landslides, and Mudslides.
SUMMARY:
1 See Docket No. RM2018–3, Order Adopting
Final Rules Relating to Non-Public Information,
June 27, 2018, Attachment A at 19–22 (Order No.
4679).
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 88, Number 37 (Friday, February 24, 2023)]
[Notices]
[Pages 11957-11958]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03826]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1150]
Bulk Manufacturer of Controlled Substances Application:
Scottsdale Research Institute
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Scottsdale Research Institute, has applied to be registered as
a bulk manufacturer of basic class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION listed below for further drug
information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 25, 2023. Such persons may also file a written request for a
hearing on the application on or before April 25, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on January 10, 2023, Scottsdale Research Institute,
12815 North Cave Creek Road, Phoenix, Arizona 85022, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
[[Page 11958]]
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract...................... 7350 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances to support clinical trials and distribution to their
customers for research purposes. No other activities for these drug
codes are authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-03826 Filed 2-23-23; 8:45 am]
BILLING CODE P
